Substituted tetracycline compounds
US9533943B2 · kind B2 · utility
4Cited by
103References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2014 |
| Grant date | Jan 3, 2017 |
| Priority date | — |
| Expiry date | May 19, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention pertains, at least in part, to novel substituted etracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.